The market for IV bag is estimated to generate a market size of USD 2,444.6 million in 2025 and would increase to USD 3,618.6 million by 2035. It is expected to increase its sales at a CAGR of 6.1% over the forecast period 2025 to 2035. Revenue generated from IV bag in 2024 was USD 2,350.6 million.
IV bags as drug delivery, with half of the market share because of their rapid absorption, precise regulation of the dose, and instant therapeutic effect, intravenous (IV) drug delivery is extensively utilized in hospitals and clinics. IV bags are frequently used in delivering drugs such as anesthesia, analgesics, antibiotics, and chemotherapeutic drugs.
The demand for such an application is also growing because there is a high rate of infection, long-term diseases, and emergency services. The growing requirement for home IV treatment of long-term diseases like dehydration and infections is another growth-driving factor in the market.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 2,444.6 Million |
| Industry Value (2035F) | USD 3,618.6 Million |
| CAGR (2025 to 2035) | 6.1% |
Intravenous therapies dominate the application segment with 60% market shares in IV bag market. Premium growth within this treatment area intravenous (IV) therapies is induced by a need for such in the existence of chronic ailments, surgeries, and hospital stays.
Intravenous administration is needed for pain, chemotherapy, and antibiotics to treat ailments. High outpatient and home-based healthcare utilization propels growth of the industry, allowing even greater IV treatment from outside hospital setups. The availability of value-driven products, including self-use IV bags that contain pre-filler solutions, generates further boost towards the development of the business.
The IV bag market will expand with lucrative opportunities during the forecast period, as it is estimated to provide an incremental opportunity of USD1268 million and will increase 1.5 times the current value by 2035.
Explore FMI!
Book a free demo
The below table presents the expected CAGR for the global IV bag market over several semi-annual periods spanning from 2024 to 2034.
| Particular | Value CAGR |
|---|---|
| H1 | 6.3% (2024 to 2034) |
| H2 | 5.9% (2024 to 2034) |
| H1 | 6.8% (2025 to 2035) |
| H2 | 5.4% (2025 to 2035) |
In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 6.3%, followed by a slightly higher growth rate of 5.9% in the second half (H2) of the same decade. Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 6.8% in the first half and remain relatively moderate at 5.4% in the second half. In the first half (H1) the market witnessed a decrease of 50 BPS while in the second half (H2), the market witnessed an increase of 50 BPS.
Increasing Demand in Healthcare for IV Therapy
The development of one of the major driving factors behind the IV bag industry is the increase in the requirement of intravenous (IV) therapy within hospitals, clinics, and home-based healthcare. Patients with a low capability of delivering fluids, medicine, or nourishments through mouth find IV bags mandatory. The procedure of IV therapy is increasing its popularity mainly due to the high demand in hydrating people, reducing pain, and cancer treatment due to growing rates of conditions such as diabetes, cancer, and renal disorders.
In addition, the market has still been increasing due to the increase in the aging population and more surgical procedures undertaken globally. Pre-filled IV solution is increasing its popularity as medical care is enhancing, thereby improving the efficiency of IV therapy as well as access. Increased cases of emergency like accidents and infection requiring immediate fluid replacement also ensure the development of the IV bag market globally.
Shifting towards Eco-Friendly IV Bags-Completely Free from PVC
Environmental issues and government regulations have enabled the medical sector to embrace IV bag manufacturing techniques that are eco-friendly and safe. PVC IV bags are infused with the plasticizer DEHP, which has the potential to be a health risk via toxicity and endocrine disruption. Many drug manufacturers and hospitals are, thus, adopting non-PVC IV bags of polypropylene, polyethylene, and ethylene-vinyl acetate (EVA).
These substitute frameworks possess great biocompatibility, reduce negative environmental effects, and meet global health and safety regulations. Additionally, various regulatory agencies and healthcare organizations prefer the utilization of recyclable and BPA-free IV bags to further reduce medical waste. Additionally, the green hospital campaign is creating higher demand for environmentally friendly and biodegradable IV packaging and open up market opportunities even greater.
Tight Rules and Difficulties with Compliance
Tight regulations face the IV bag industry because medical devices must meet stringent safety and quality requirements established by organizations such as the FDA (USA), EMA (Europe), and WHO. The regulations ensure that IV bags are free from chemicals, sterile, and non-toxic. It may be costly and time-consuming, however, to achieve compliance, especially for small manufacturers. Long processing times and frequent policy fluctuations in the health sector also delay product launches and increase R&D expenses.
Production becomes more cumbersome with the demand for new ways of production and testing procedures ushered in by the transition to non-PVC products. The challenges of quality control problems created by concerns for product recalls and contamination risks further complicate business growth on an international scale.
| Key Investment Area | Why It’s Critical for Future Growth |
|---|---|
| Sustainability & Eco-Friendly Materials | PVC-free, biodegradable, and recyclable IV bags will be an investment that reduces medical waste and complies with international environmental standards. |
| Improved Safety & Sterility | Building materials resistant to contamination and modern sterilization methods will protect the patient as well as conform to healthcare requirements. |
| Customization & Multi-Chamber Designs | Providing IV bags of varying capacities, multi-chamber designs, and compatibility with a range of medications will enhance treatment effectiveness. |
| Lightweight & Durable Solutions | Material composition optimization will improve portability, minimize the risk of breakage, and lower transportation costs. |
| Automation & High-Speed Manufacturing | Enabling sophisticated production processes, like blow-fill-seal (BFS) technology, will enhance efficiency, reliability, and scalability. |
The global IV bag market achieved a CAGR of 4% in the historical period of 2020 to 2024. Overall, the IV bag market performed well since it grew positively and reached USD 2,350.6 million in 2024 from USD 1,854.9 million in 2020.
The IV bag market grew consistently between 2020 and 2024 due to the surging demand for intravenous fluid delivery in hospitals, clinics, and home health care. The prevalence of chronic diseases, dehydration, and surgeries spurred market growth. New developments in PVC-free and non-toxic IV bag materials enhanced patient safety, and the transition towards single-use and sterile IV solutions also drove uptake.
| Market Aspect | 2020 to 2024 (Past Trends) |
|---|---|
| Material Trends | Extensive use of PVC, polypropylene (PP), and polyethylene (PE) IV bags. |
| Regulatory Environment | Conformity with FDA, EU MDR, and WHO regulations of medical packaging safety. |
| Consumer Demand | Intense demand from hospitals, clinics, and ambulatory care centers for single-use, sterilized IV bags. |
| Technological Innovation | Launch of multi-chamber IV bags, enhanced sterilization, and leak-proof constructions. |
| Sustainability Initiatives | Making medical plastic waste reduction and IV bag recycling initiatives more robust. |
| Market Aspect | 2025 to 2035 (Future Projections) |
|---|---|
| Material Trends | Transition towards non-PVC, DEHP-free, and biodegradable IV bags for improved patient safety and environmental advantages. |
| Regulatory Environment | Tighter regulations on plastic-free medical packaging, minimizing toxic additives, and enhanced biocompatibility standards. |
| Consumer Demand | Growing demand for smart IV bags with real-time monitoring, self-administration features, and eco-friendly materials. |
| Technological Innovation | Development of self-regulating IV bags, RFID-monitored infusion sets, and AI-based fluid monitoring. |
| Sustainability Initiatives | Robust drive for completely recyclable, bio-based IV bags and energy-saving production processes. |
| Factor | Consumer Priorities (2019 to 2024) & (2025 to 2035) |
|---|---|
| Product Availability & Convenience |
|
| Sustainability |
|
| Cost & Pricing |
|
| Performance (Durability, Leakage Resistance, Shelf Life) |
|
| Regulatory Compliance & Safety |
|
| Smart Technology & Customization |
|
| Factor | Manufacturer Priorities (2019 to 2024) & (2025 to 2035) |
|---|---|
| Product Availability & Convenience |
|
| Sustainability |
|
| Cost & Pricing |
|
| Performance (Durability, Leakage Resistance, Shelf Life) |
|
| Regulatory Compliance & Safety |
|
| Smart Technology & Customization |
|
The period between 2025 and 2035 is anticipated to witness an increase in the demand for IV bags on account of an aging population, rising hospital admissions, and the growth of home healthcare services. The emphasis on biodegradable and recyclable IV bag material will be driving innovation as more healthcare centers take up sustainable strategies.
Moreover, the emergence of smart IV bags with sensors embedded to track the level of fluids and patient parameters will increase efficiency and patient safety. The growth of emergency care services, ambulatory care, and sophisticated drug delivery systems will drive market growth further.
Tier 1 companies comprise market leaders capturing significant market share in global market. These market leaders are characterized by high production capacity and a wide product portfolio. These market leaders are distinguished by their extensive expertise in manufacturing across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series including recycling and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality. Prominent companies within tier 1 include Mountainside Medical Equipment, Kraton Performance Polymers Inc., Renolit, Angiplast Pvt. Ltd, Medline Industries.
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market. These are characterized by a strong presence overseas and strong market knowledge. These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Baxter, Sippex IV Bag, Wipak Group Management, B. Braun Medical Inc., ICU Medical, Inc., Guangdong Lejin Medicine Co., Ltd, Fresenius Kabi Group.
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche markets. These companies are notably oriented towards fulfilling local market demands and are consequently classified within the tier 3 share segment. They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized market, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
Region-Wise Trends: Past Analysis (2019 to 2024) and Future Projections (2025 to 2035)
| Region | 2019 to 2024 (Past Trends) |
|---|---|
| North America | Increased demand owing to sophisticated healthcare infrastructure and growing chronic diseases. |
| Latin America | Moderate growth spearheaded by growth in healthcare establishments and medical progress. |
| Europe | Dominant market because of strong regulations of medical plastics and minimization of waste. |
| Middle East & Africa | Increasing demand owing to the growing healthcare needs and investments in healthcare infrastructure. |
| Asia Pacific | Most rapidly expanding market because of increasing hospitalizations, aging population, and healthcare reforms. |
| Region | 2025 to 2035 (Future Projections) |
|---|---|
| North America | Transition towards PVC-free and biodegradable IV bags as a sustainability measure for the environment. |
| Latin America | Growing domestic investment in producing IV bags at home and switching to environmentally friendly materials. |
| Europe | Increased utilization of recyclable and biocompatible IV bags to comply with regulations. |
| Middle East & Africa | Growth in localized production and use of intelligent IV bag technology. |
| Asia Pacific | Mass production and innovation in lightweight, non-toxic IV bag materials. |
The section below covers the future forecast for the IV bag market in terms of countries. Information on key countries in several parts of the globe, including North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe and MEA is provided. USA is expected to account for a CAGR of 4.6% through 2035. In Europe, Spain is projected to witness a CAGR of 5.7% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 5.0% |
| Germany | 4.6% |
| China | 7.0% |
| UK | 4.5% |
| Spain | 5.7% |
| India | 7.2% |
| Canada | 4.8% |
Portable IV bags are increasingly employed in the United States due to the increased need for outpatient care and home healthcare services. IV therapy is often delivered at home and not within hospitals for patients with palliative care requirements, chronic diseases, or post-operative recuperation needs. Patients can now get IV fluids, antibiotics, or nutritional therapy without ever having to set foot in the hospital due to the expansion of telehealth and home infusion therapy services.
Single-use, easy-to-manage IV bags are also increased by cost-saving efforts in healthcare that encourage outpatient procedures to reduce the length of stay in the hospital. In order to meet the increasing need for home care in America, manufacturers are developing IV products that are flexible, light in weight, and pre-filled.
Sophisticated IV bag solutions are highly sought after because of Germany's strict hospital hygiene, sterility, and medical waste management policies. To avoid infections and maintain strict safety policies, German hospitals give high importance to single-use, contamination-free IV bags. Hospitals are also being prompted to utilize recyclable, non-toxic IV packaging by the country's focus on sustainability and circular economy policies.
As a result of environmental issues and EU directives, most German medical facilities are slowly switching from PVC IV bags to non-leaching and biodegradable options. As a result, medical suppliers are creating high-barrier, eco-friendlier IV bag materials that meet Germany's high environmental and medical standards.
The section contains information about the leading segments in the industry. In terms of material type, Polyvinyl Chloride (PVC)is being estimated to account for a share of 46% by2025. By chamber type, single chamber IV bags is projected to dominate by holding a share above58% by the end2025.
| Material Type | Market Share (2025) |
|---|---|
| Polyvinyl Chloride (PVC) | 46% |
The cost-savings, long life, and versatility of PVC make it the most popular polymer in the IV bag industry. Extremely functional and possessing great barrier properties for aseptic and safe preservation of IV fluids, PVC, even threatened by plasticizers such as DEHP, still commands much of the market because of the advances in the use of DEHP-free materials.
To cite other benefits, PVC bags are also light and break-resistant and have been used globally in hospitals and clinics. Some manufacturers are producing other recyclable and eco-friendly alternatives, but PVC remains the market leader.
| Chamber Type | Market Share (2025) |
|---|---|
| Single Chamber IV Bags | 58% |
Single chamber IV bags possess the largest market share in IV bags because of their cost-effectiveness, simplicity of use, and universal use. They are generally applied in hydration therapy, electrolyte replacement, and medication administration.
Single chamber bags are preferred by hospitals and healthcare institutions for their easy design, less chance of contamination, and usability with various IV solutions. Moreover, companies are innovating with PVC-free products, being in line with environmental and safety standards while continuing to lead the market.
The IV bags market is growing at a very fast pace with the increasing demand for intravenous therapy in home health care, ambulatory care facilities, and hospitals. IV bags are crucial medical devices that provide nutrients, medication, fluids, and electrolytes directly into the bloodstream. The demographic change, increased incidence of chronic diseases, and enhanced demand for parenteral nutrition are driving the market.
As a result of strict laws on medical-grade plastics due to health issues relating to plasticizers and associated health hazards, switching to IV bags that are PVC- and DEHP-free is one of the key market trends. Furthermore, technology developments in aseptic filling, ready-to-use products, and multi-chamber IV bags are further improving product efficiency and safety. Smart IV bags with digital monitoring functions are also redefining competition in the industry.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Baxter International Inc. | 20-25% |
| B. Braun Melsungen AG | 15-20% |
| Fresenius Kabi AG | 12-16% |
| ICU Medical, Inc. | 8-12% |
| Sippex IV Bag Solutions | 5-8% |
| Company Name | Key Offerings/Activities |
|---|---|
| Baxter International Inc. | Develops PVC-free and DEHP-free IV bags, focusing on parenteral nutrition and fluid therapy solutions. |
| B. Braun Melsungen AG | Specializes in multi-chamber IV bags and ready-to-use intravenous solutions, prioritizing safety and efficiency. |
| Fresenius Kabi AG | Manufactures high-quality infusion therapy products, including biocompatible and eco-friendly IV bags. |
| ICU Medical, Inc. | Offers advanced IV bags integrated with drug delivery systems and smart monitoring capabilities. |
| Sippex IV Bag Solutions | Focuses on customizable and sterile IV bags, catering to pharmaceutical and hospital needs. |
Key Company Insights
Baxter International Inc. (20%-25%)
Baxter is one of the manufacturers of IV bags, providing PVC-free, DEHP-free, and multi-chamber IV bags. Baxter maintains a dominant share in parenteral nutrition and intravenous therapy business with ready-to-use IV products for hospitals as well as clinics.
B. Braun Melsungen AG (15%-20%)
B. Braun excels in multi-chamber IV bags and closed infusion systems that minimize the risk of contamination and guarantee safe medication administration. B. Braun is a leader in sustainable and environmentally friendly IV packaging solutions.
Fresenius Kabi AG (12%-16%)
Fresenius Kabi produces intravenous liquids, electrolyte fluids, and infusion therapy solutions, where biodegradable and high-barrier IV bags are a major focus. The company is expanding ready-to-use IV fluids for enhanced efficiency in the healthcare environment.
ICU Medical, Inc. (8%-12%)
ICU Medical combines IV therapy with digital health solutions, providing smart IV bags that track fluid delivery in real time. The company emphasizes closed-loop medication infusion systems for increased patient security.
Sippex IV Bag Solutions (5%-8%)
Sippex offers private IV bag solutions in the form of sterile, medical-grade infusion bags designed specifically for pharmaceutical and hospital needs. The company is also pioneering the manufacturing of non-PVC IV bags.
Other Notable Participants (30-40% Together)
A variety of smaller yet powerful participants enhance the IV Bag Market through their specialty and cutting-edge solutions:
Key Developments in IV Bag Market
The global IV bag industry is projected to witness CAGR of 6.1% between 2025 and 2035.
The global IV bag industry stood at 2,444.6 million in 2025.
Global IV bag industry is anticipated to reach USD 3,618.6 million by 2035 end.
East Asia is set to record a CAGR of 7.2% in assessment period.
The key players operating in the global IV bag industry include Mountainside Medical Equipment, Kraton Performance Polymers Inc., Renolit, Angiplast Pvt. Ltd, Medline Industries.
The IV bag market is categorized by material type, including polyethylene (PE), polyvinyl chloride (PVC), ethylene vinyl acetate (EVA), polypropylene (PP), copolyester ether, and other materials.
The market is segmented based on IV bag size, including less than 250 ml, 250 ml to 500 ml, 500 ml to 1000 ml, and more than 1000 ml.
IV bags are classified by chamber type into single chamber and multiple chamber variants.
The market is segmented by application into parenteral nutrition and intravenous therapies.
IV bags are used for various purposes, including correcting electrolyte imbalances, delivering medications, blood transfusions, blood storage, and other end uses.
Key Countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa are covered.
BOPP Film Market Analysis by Thickness, Packaging Format, and End-use Industry Through 2025 to 2035
Korea Tape Dispenser Market Analysis by Material, Product Type, Technology, End Use, and Region through 2025 to 2035
Japan Heavy-duty Corrugated Packaging Market Analysis based on Product Type, Board type, Capacity, End use and City through 2025 to 2035
Corrugated Board Market Analysis by Material and Application Through 2035
Waterproof Packaging Market Trends - Demand & Industry Forecast 2025 to 2035
Thermochromic Labels Market Insights - Innovations & Growth 2025 to 2035
IV Bag Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
